Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): Follow-up on hormone replacement therapy and osteoporosis risk assessment

Journal of Clinical Endocrinology and Metabolism

Volumn 80, Issue 3, 1995, Pages 864-868

  Bonde, Martin ^a   Qvist, Per ^a   Fledelius, Christian ^a   Riis, Bente Juel ^b   Christiansen, Claus ^b  

^a NORDIC BIOSCIENCE A S   (Denmark)

^b CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; CREATININE; CYPROTERONE ACETATE; DEOXYPYRIDINOLINE; DESOGESTREL; ESTRADIOL; HYDROXYPROLINE; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; OSTEOCALCIN; PLACEBO; PYRIDINE DERIVATIVE; PYRIDINOLINE;

ADULT; ARTICLE; BLOOD LEVEL; BONE MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; ORAL DRUG ADMINISTRATION; OSTEOLYSIS; OSTEOPOROSIS; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; URINE LEVEL;

AMINO ACID SEQUENCE; AMINO ACIDS; BIOLOGICAL MARKERS; BONE RESORPTION; COLLAGEN; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OSTEOPOROSIS; RISK;

EID: 0028923618     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.80.3.7883844     Document Type: Article

References (23)

1. Delmas PD. 1991 Biochemical markers of bone turnover: methodology and clinical use in osteoporosis. Am J Med. 91(Suppl 5B): 59S-63S.
2. Lauffenburger T, Olah AJ, Dambacher MA, Guncaga J, Lentner C, Haas HG. 1977 Bone remodeling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget’s disease. Metabolism. 26: 589-606.
3. Aloia JF, Cohn SH, Zanzi I, Abesamis C, Elis K. 1978 Hydroxypro-line peptides and bone mass in postmenopausal and osteoporotic women. J Clin Endocrinol Metab. 47:314-318.
4. Nordin BEC. 1978 Diagnostic procedures in disorders of calcium metabolism. Clin Endocrinol (Oxf). 8:55-67.
5. Burgeson RE. 1988 New collagens, new concepts. Annu Rev Cell Biol 4:551-577.
6. Seyedin SM, Kung VT, Daniloff YN, et al. 1993 Immunoassay for urinary pyridinoline: the new marker of bone resorption. J Bone Miner Res 8:635-641.
7. Risteli J, Niemi S, Elomaa T, Risteli J. 1991 Bone resorption assay based on a peptide liberated during type I collagen degradation [Abstract 637]. J Bone Miner Res. 6(Suppl 1):S251.
8. Hanson DA, Weis MAE, Bollen A-M, Maslan SL, Singer FR, Eyre DR. 1992 A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res. 7:1251-1258.
9. Riis BJ, Thomsen K, Strom V, Christiansen C. 1987 The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss. Am J Med. 1:61-65.
10. Riis BJ, Jensen J, Christiansen C. 1987 Cyproterone acetate, an alternative gestagen in postmenopausal estrogen/gestagen therapy? Clin Endocrinol (Oxf). 26:327-334.
11. 3 prevent postmenopausal bone loss? Calcif Tissue Int. 39: 128-132.
12. Marslew U, Riis BJ, Christiansen C. 1991 Desogestrel in hormone replacement therapy: long-term effects of bone, calcium, and lipid metabolism, climacteric symptoms, and bleeding. Eur J Clin Invest. 21:601-607.
13. Marslew U, Overgaard K, Riis BJ, Christiansen C. 1992 Two new combinations for prevention of postmenopausal bone loss: longterm effects on bone, calcium, and lipid metabolism, climacteric symptoms, and bleeding. Obstet Gynecol. 79:202-210.
14. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C. Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem. 40: 2022-2025.
15. Uebelhart, Gineyts E, Chapuy M-C, Delmas PD. 1990 Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Miner. 8:87-96.
16. Pødenphant J, Larsen N-E, Christiansen C. 1984 An easy and reliable method for determination of urinary hydroxyproline. Clin Chim Acta. 142:145-148.
17. Johansen JS, Mølholm Hansen JE, Christiansen C. 1987 A radioimmunoassay for bone Gla protein (BGP) in human plasma. Acta Endocrinol (Copenh). 114:410-416.
18. Nilas L, Borg J, Gotfredsen A. 1985 Comparison of single and dual photon absorptiometry in postmenopausal bone loss. J Nucl Med. 26:1257-62.
19. Hansen MA, Hassager C, Overgaard K, Marslew U, Riis BJ, Christiansen C. 1990 Dual-energy x-ray absorptiometry: a precise method of measuring bone mineral density in the lumbar spine. J Nucl Med. 31:1156-1162.
20. Christiansen C, Riis BJ, Rødbro P. 1987 Prediction of rapid bone loss in postmenopausal women. Lancet. 1:1105-1108.
21. Christiansen C, Riis BJ, Rødbro P. 1990 Screening procedure for women at risk of developing postmenopausal osteoporosis. Osteo-poris Int. 1:35-40.
22. Hansen MA, Overgaard K, Riis BJ, Christiansen C. 1991 Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. Br Med J. 303:961-964.
23. Christiansen C. 1984 Prophylactic treatment for age-related bone loss in women. In: Christiansen C, Arnaud CD, Nordin BEC, et ah, eds. Osteoporosis. Proceedings of Copenhagen International Symposium on Osteoporosis. Copenhagen: Osteopress A/S; 587-593.